Contents

Search

JC virus antibody

Indications: - assessment of exposure to JC virus, including risk for progressive multifocal leukoencephalopathy in patients taking natalizumab (Tsabri) for treatment of multiple sclerosis or Crohn's disease Clinical significance: - antibodies to JC virus are present in 80% of adults Method: ELISA

Related

JC virus

General

serology for infectious agent

References

  1. FDA NEWS RELEASE: January 20, 2012 FDA permits marketing of first test for risk of rare brain infection in some people treated with Tysabri http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm288471.htm